MedPath

An Artificial Intelligence-Assisted Digital Health Lifestyle Intervention for Adults With Hypertension

Not Applicable
Completed
Conditions
Hypertension
Interventions
Behavioral: AI-Driven Lifestyle Coaching Program
Registration Number
NCT06337734
Lead Sponsor
University of California, San Diego
Brief Summary

This study evaluates the impact of a fully digital, autonomous, and artificial intelligence (AI)-driven lifestyle coaching program on managing blood pressure (BP) among adults diagnosed with hypertension. Participants received a BP monitor and a wearable activity tracker to facilitate data collection. This data, along with responses from a questionnaire mobile app, were analyzed by an automated analytics engine employing statistical and machine learning techniques. The program delivered tailored lifestyle coaching directly to participants through a mobile app, aiming for precise and effective BP management.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
141
Inclusion Criteria
  • Age ≥18 years
  • Stage 2 hypertension based on their most recent clinical measurement (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg per the 2017 American College of Cardiology/American Heart Association guidelines)
  • Speaking and reading English
  • Having an Apple iPhone 6s or later, or an Android phone running Android 8.0 or later
Exclusion Criteria
  • Self-reported diagnosis of coronary heart disease, medical condition or other physical problem necessitating special attention in an exercise program (e.g., cancer, eating disorder, uncontrolled diabetes)
  • Current participation in a lifestyle modification program or research study
  • Self-report of being currently pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AI-Driven Lifestyle Coaching GroupAI-Driven Lifestyle Coaching Program-
Primary Outcome Measures
NameTimeMethod
Average change in DBP from baseline to 24 weeks24 weeks
Percent change of participants with controlled BP (SBP<130 and DBP<80) from baseline to 12 weeks12 weeks
Percent change of participants with controlled BP (SBP<130 and DBP<80) from baseline to 24 weeks24 weeks
Percent change of participants with Stage 2 Hypertension (SBP≥140 or DBP≥90) from baseline to 24 weeks24 weeks
Average change in systolic blood pressure (SBP) from baseline to 12 weeks12 weeks
Average change in diastolic blood pressure (DBP) from baseline to 12 weeks12 weeks
Average change in SBP from baseline to 24 weeks24 weeks
Percent change of participants with Stage 2 Hypertension (SBP≥140 or DBP≥90) from baseline to 12 weeks12 weeks
Secondary Outcome Measures
NameTimeMethod
Average weekly percentage of active participants measuring their BP24 weeks
Average weekly percentage of active participants syncing their wearable24 weeks
Average weekly percentage of active participants answering the mobile app questionnaire24 weeks
Number of manual clinician outreaches based on the escalation rules set for the study24 weeks

Trial Locations

Locations (1)

University of California, San Diego

🇺🇸

La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath